A clinical trial of Domiphen bromide/miconazole for vulvovaginal candidiasis
Latest Information Update: 25 Mar 2024
At a glance
- Drugs Domiphen bromide/miconazole (Primary)
- Indications Vulvovaginal candidiasis
- Focus Adverse reactions
- 14 Mar 2024 According to a Hyloris Pharmaceuticals media release, the company plans to initiate this trial by year-end 2024.
- 11 Feb 2021 New trial record
- 05 Feb 2021 According to a Hyloris Pharmaceuticals media release, the company plans to initiate this trial in 2021.